26 unknown. 26 Phase 2, 8 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 26 | Unknown 26 |
| Phase 3 | 8 | Unknown 8 |
| Phase 1 | 2 | Unknown 2 |
Follow Epilepsy: new trials by email Literature Review of Epilepsy trials Research Report on Epilepsy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cortical Excitability in West Syndrome Using Transcranial Magnetic Stimulation ACTH/Oral Steroids - West Syndrome | Phase 2 / Phase 3 | Unknown | All India Institute of Medical Sciences | 40 | 2024-03-01 | 2024-03-04 |
| Modified Atkins Diet Versus Topiramate In Children With Epileptic Spasms Refractory To Hormonal Treatment: A Randomized Open-Label Study Modified Atkins diet, Topiramate - Epileptic Spasms, Failed Hormonal Therapy | Phase 2 / Phase 3 | Unknown | Lady Hardinge Medical College | 70 | 2023-07-20 | 2023-07-24 |
| Electrical Neuromodulation for Focal Epilepsy Soterix MXN-5 HD-tES Model 5005A. Medtronic Percept DBS platform. - Epilepsy | Phase 1 / Phase 2 | Unknown | National Taiwan University Hospital | 65 | 2023-05-01 | 2023-05-09 |
| Adjunctive Everolimus Treatment of Refractory Epilepsy Everolimus, Placebo - Epilepsy | Phase 2 | Unknown | National Institute on Drug Dependence, China | 108 | 2022-11-01 | 2022-11-14 |
| Ketogenic Diet vs ACTH for the Treatment of Children With West Syndrome Ketogenic diet, ACTH - Ketogenic Diet, West Syndrome | Phase 2 / Phase 3 | Unknown | All India Institute of Medical Sciences | 80 | 2022-04-18 | 2024-06-25 |
| Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy Placebo, EQU-001 - Epilepsy | Phase 2 | Unknown | Equilibre Biopharmaceuticals B.V. | 43 | 2021-08-31 | 2023-05-15 |
| Treating Postictal Symptoms Using Ibuprofen and Nifedipine Ibuprofen, Nifedipine, Placebo - Epilepsy, Epilepsies, Partial | Phase 2 | Unknown | University of Calgary | 90 | 2021-02-01 | 2024-05-09 |
| Efficacy, Safety and Pharmacokinetics of ES-481 in Adult Patients With Drug Resistant Epilepsy ES-481, Placebo, Open-Label Extension Study - Drug Resistant Epilepsy | Phase 2 | Unknown | ES Therapeutics Australia Pty Ltd | 24 | 2020-10-30 | 2023-03-02 |
| Pilot Trial to Evaluate The Effect of Oral Methylprednisolone on Seizure Frequency in Children With Epilepsy methylprednisolone sodium succinate, Placebo - Intractable Epilepsy, Convulsive Seizures | Phase 1 / Phase 2 | Unknown | Louisiana State University Health Sciences Center in New Orleans | 10 | 2020-02-03 | 2020-02-07 |
| Intravenous Methylprednisolone Versus Oral Prednisolone for Infantile Spasms Intravenous Methylprednisolone, Oral Pednisolone - Infantile Spasm | Phase 2 / Phase 3 | Unknown | Suvasini Sharma | 128 | 2019-04-01 | 2019-11-18 |
| Evaluation of the Modified Atkins Diet in Children With Epileptic Spasms Modified Atkins diet - Epileptic Spasms | Phase 2 / Phase 3 | Unknown | Lady Hardinge Medical College | 90 | 2019-01-15 | 2019-02-05 |
| Voronistat in Pediatric Patients With Drug Resistant Epilepsy Vorinostat 100 MG - Refractory Epilepsy | Phase 2 | Unknown | University of Calgary | 12 | 2018-12-10 | 2019-03-29 |
| Outcomes Mandate National Integration With Cannabis as Medicine Cannabis, Medical, RYAH-Medtech Inhaler - Chronic Pain, Chronic Pain Syndrome | Phase 2 | Unknown | OMNI Medical Services, LLC | 200000 | 2018-12-01 | 2022-06-02 |
| Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex Aspirin, AED, Placebo - Tuberous Sclerosis Complex, Aspirin | Phase 2 | Unknown | Peking Union Medical College Hospital | 98 | 2017-11-20 | 2020-06-09 |
| Fecal Microbiota Transplantation for Epilepsy Fecal microbiota suspension - Epilepsy | Phase 2 / Phase 3 | Unknown | The Second Hospital of Nanjing Medical University | 50 | 2016-11-01 | 2024-03-20 |
| Efficacy of Omega-3 as Adjunctive Therapy for Medically Intractable Epilepsy: A Prospective Open-label Pilot Study Omega-3 - Epilepsy | Phase 2 | Unknown | Seoul National University Hospital | 30 | 2016-08-01 | 2018-04-20 |
| Effect of Outpatient Classic Ketogenic Diet in Epileptic Children and Adolescent. ketogenic diet - Refractory Epilepsy | Phase 2 | Unknown | Tehran University of Medical Sciences | 30 | 2016-07-01 | 2017-01-25 |
| Impact of Neuropsychological Evaluation on Epilepsy Treatment Neuropsychological testing - Epilepsy | Phase 2 | Unknown | University of South Florida | 100 | 2015-07-01 | 2017-06-28 |
| Development and Clinical Application of [11C]Verapamil-PET [11C] -verapamil PET - Epilepsy | Phase 2 | Unknown | Seoul National University Hospital | 30 | 2013-05-01 | 2014-05-22 |
| Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy ketogenic diet - Epilepsy | Phase 2 | Unknown | Mid-Atlantic Epilepsy and Sleep Center, LLC | 30 | 2013-01-01 | 2018-02-23 |
Showing 20 of 26. Sign in to see all of them.
Drug Resistant Epilepsy (5) · Seizures (5) · Spasms, Infantile (5) · Headache (2) · Migraine Disorders (2) · Acquired Immunodeficiency Syndrome (1) · Amyotrophic Lateral Sclerosis (1) · Anemia, Sickle Cell (1) · Anxiety Disorders (1) · Autistic Disorder (1) · Bipolar Disorder (1) · Brain Injuries, Traumatic (1) · COVID-19 (1) · Chronic Pain (1)
Brain Diseases (26) · Central Nervous System Diseases (26) · Nervous System Diseases (26) · Neurologic Manifestations (8) · Pathological Conditions, Signs and Symptoms (8) · Signs and Symptoms (8) · Epilepsy, Generalized (6) · Epileptic Syndromes (6) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Genetic Diseases, Inborn (3) · Heredodegenerative Disorders, Nervous System (3) · Neurodegenerative Diseases (3) · Pain (3) · Behavior (2)
Diet, Ketogenic (4) · Adrenocorticotropic Hormone (1) · Anticonvulsants (1) · Aspirin (1) · Diet Therapy (1) · Docosahexaenoic Acids (1) · Everolimus (1) · Exercise (1) · Ibuprofen (1) · Medical Marijuana (1) · Methylprednisolone Hemisuccinate (1) · Neuropsychological Tests (1) · Nifedipine (1) · Octagam (1) · Omacor (1)
All India Institute of Medical Sciences (2) · Lady Hardinge Medical College (2) · Seoul National University Hospital (2) · University of Calgary (2) · Danish Headache Center (1) · ES Therapeutics Australia Pty Ltd (1) · Equilibre Biopharmaceuticals B.V. (1) · Lars Bo Andersen (1) · Louisiana State University Health Sciences Center in New Orleans (1) · Mid-Atlantic Epilepsy and Sleep Center, LLC (1) · NMT Medical (1) · National Institute on Drug Dependence, China (1) · National Taiwan University Hospital (1) · OMNI Medical Services, LLC (1) · Peking Union Medical College Hospital (1)
United States (7) · India (5) · China (3) · Canada (2) · Denmark (2) · South Korea (2) · Australia (1) · Finland (1) · Germany (1) · Iran (1) · Israel (1)
Christian G Bien, M.D. (1) · Dipti Kapoor, MD (1) · Dr. Ryan O Lakin, MD JD (1) · Faming Zhang, MD,PhD (1) · Jeremy Toler, MD (1) · Jong Rho, MD (1) · Kon Chu, MD, PhD (1) · Lars Bo Andersen, Professor (1) · Mark Reisman, MD (1) · Maryam Mahmoudi, MD, PHD (1) · Paolo Federico, MD, PhD (1) · Pavel Klein, MD (1) · Peer Tfelt-Hansen, MD, Dr Med Sci (1) · Qing Liu, MD PhD (1)
PMID 29373639, PMID 33575989, PMID 33834913, PMID 34389161, PMID 40840039, PMID 42312676, PMID 42473187